NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity, Fitness & Wellness Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity, Fitness & Wellness Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Neovascularization



Researchers from University of North Carolina, Department of Ophthalmology report recent findings in neovascularization



December 30th, 2006

New investigation results, "Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy," are detailed in a study published in Investigative Ophthalmology & Visual Science. In this recent report, researchers in the United States conducted a study "To study the effects of intravitreous triamcinolone acetonide (TA) on neovascularization (NV), capillary density, and retinal endothelial cell (REC) viability in a model of oxygen-induced retinopathy (OIR). Newborn rats exposed to OIR underwent intravitreous injections (right eye) at day 14 to achieve intravitreous concentrations of: dexamethasone (DEX) (0.3 mg/mL),...


Source: Obesity, Fitness & Wellness Week (2006-12-30)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login